Literature DB >> 20452459

Effect of the dibenzylbutyrolactone lignan (-)-hinokinin on doxorubicin and methyl methanesulfonate clastogenicity in V79 Chinese hamster lung fibroblasts.

Flávia Aparecida Resende1, Iara Maluf Tomazella, Lilian Cristina Barbosa, Marina Ponce, Ricardo Andrade Furtado, Ana Carolina Pereira, Jairo Kenupp Bastos, Márcio Luís Andrade E Silva, Denise Crispim Tavares.   

Abstract

The dibenzylbutyrolactone lignan (-)-hinokinin (HK) was obtained by partial synthesis from (-)-cubebin, isolated from the dry seeds of the pepper, Piper cubeba. In view of the trypanocidal activity of HK and its potential as a lead compound for drug development, evaluation of its possible genotoxic activity is required. We have tested HK for possible genotoxicity and evaluated the compound's effect on the activity of the clastogens doxorubicin (DXR) and methyl methanesulfonate (MMS) in the micronucleus (MN) assay with Chinese hamster lung fibroblast V79 cells. HK alone did not induce MN, at concentrations up to 128microM. In combined treatments, HK reduced the frequency of MN induced by MMS. With respect to DXR, HK exerted a protective effect at lower concentrations, but at higher concentrations it potentiated DXR clastogenicity. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452459     DOI: 10.1016/j.mrgentox.2010.04.023

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Mutagenicity and antimutagenicity of (-)-hinokinin a trypanosomicidal compound measured by Salmonella microsome and comet assays.

Authors:  Flávia Aparecida Resende; Lilian Cristina Barbosa; Denise Crispim Tavares; Mariana Santoro de Camargo; Karen Cristina de Souza Rezende; Márcio Luis de Andrade E Silva; Eliana Aparecida Varanda
Journal:  BMC Complement Altern Med       Date:  2012-10-31       Impact factor: 3.659

2.  Identifying Mazama gouazoubira (Artiodactyla; Cervidae) chromosomes involved in rearrangements induced by doxorubicin.

Authors:  Iara Maluf Tomazella; Vanessa Veltrini Abril; José Maurício Barbanti Duarte
Journal:  Genet Mol Biol       Date:  2017-06-05       Impact factor: 1.771

Review 3.  An Ethnopharmacological, Phytochemical and Pharmacological Review on Lignans from Mexican Bursera spp.

Authors:  Maria Carla Marcotullio; Massimo Curini; Judith X Becerra
Journal:  Molecules       Date:  2018-08-08       Impact factor: 4.411

4.  Comparative Studies of the (Anti) Mutagenicity of Baccharis dracunculifolia and Artepillin C by the Bacterial Reverse Mutation Test.

Authors:  Flávia Aparecida Resende; Carla Carolina Munari; Moacir de Azevedo Bentes Monteiro Neto; Denise Crispim Tavares; Jairo Kenupp Bastos; Ademar Alves da Silva Filho; Eliana Aparecida Varanda
Journal:  Molecules       Date:  2012-02-24       Impact factor: 4.411

5.  Genotoxicity and Cytotoxicity Evaluation of the Neolignan Analogue 2-(4-Nitrophenoxy)-1Phenylethanone and its Protective Effect Against DNA Damage.

Authors:  Alex Lucas Hanusch; Guilherme Roberto de Oliveira; Simone Maria Teixeira de Sabóia-Morais; Rafael Cosme Machado; Murilo Machado Dos Anjos; Lee Chen Chen
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

6.  Evaluation of the genotoxic and antigenotoxic effects of Chios mastic water by the in vitro micronucleus test on human lymphocytes and the in vivo wing somatic test on Drosophila.

Authors:  Dimitris Vlastos; Despoina Mademtzoglou; Elena Drosopoulou; Ioanna Efthimiou; Tatiana Chartomatsidou; Christina Pandelidou; Melina Astyrakaki; Eleftheria Chalatsi; Penelope Mavragani-Tsipidou
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

7.  Modulatory Effect of Betulinic Acid on the Genotoxicity Induced by Different Mutagens in V79 Cells.

Authors:  Nathália Oliveira Acésio; Pollyanna Francielli de Oliveira; Daiane Fernanda Pereira Mastrocola; Ildercílio Mota de Souza Lima; Carla Carolina Munari; Vânia Luiza Ferreira Lucatti Sato; Andressa Aparecida Silva Souza; Lúzio Gabriel Bocalon Flauzino; Wilson Roberto Cunha; Denise Crispim Tavares
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-19       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.